Skip to main content
. 2015 Jun 5;119(3):266–271. doi: 10.1152/japplphysiol.00455.2014

Table 1.

General demographics

Variable Controls COPD Patients P Value
n 18 18
Anthropometry
    Age, yr 50.3 ± 1.6 57.1 ± 1.9 <0.05
    Height, cm 170.0 ± 2.7 174.2 ± 2.1 NS
    Weight, kg 97.9 ± 6.6 86.5 ± 4.1 NS
    BMI, kg/m2 31.6 ± 1.6 28.6 ± 1.2 NS
    Sex 12M; 6 F 12M; 6 F NS
Lung volumes
    FEV1, liters 3.1 ± 0.2 1.9 ± 0.2 < 0.05
    FEV1/FVC, % 79 ± 1.2 54 ± 2.6 <0.05
    TLC, liters 5.9 ± 0.3 6.7 ± 0.2 < 0.05
    RV, liters 1.9 ± 0.1 3.0 ± 0.2 <0.05
    FRC, liters 2.8 ± 0.2 4.0 ± 0.2 < 0.05
    RV/TLC, % 33.8 ± 1.8 45.5 ± 2.4 <0.05
Polysomnography
    TST, min 365.6 ± 10.7 353.7 ± 15.9 NS
    Sleep efficiency, %TST 86.9 ± 2.0 79.4 ± 3.0 <0.05
    NREM, %TST 84.7 ± 1.5 83.9 ± 1.9 NS
        Stage 1 19.2 ± 2.4 27.1 ± 5.2 NS
        Stage 2 60.2 ± 2.5 50.8 ± 4.3 NS
        Stage 3 5.2 ± 1.8 6.0 ± 2.3 NS
    REM, %TST 15.3 ± 1.5 16.1 ± 1.9 NS
    Total AHI, events/h 28.9 ± 8.1 28.9 ± 8.6 NS
    NREM AHI, events/h 27.8 ± 8.1 28.2 ± 8.6 NS
    REM AHI, events/h 36.1 ± 7.7 33.3 ± 10.0 NS
        %Hypopnea NREM 76.9 ± 6.1 75.9 ± 6.7 NS
        %Hypopnea REM 73.3 ± 7.3 62.2 ± 8.6 NS
    Arterial SaO2, %
        Average baseline value 96.4 ± 0.4 93.9 ± 0.5 <0.05
        Average low value 91.5 ± 0.7 90.2 ± 0.6 NS

Values are averages ± SE of main demographic parameters for both groups; n, no. of subjects. COPD, chronic obstructive pulmonary disease; BMI, body mass index; M, male; F, female; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; TLC, total lung capacity; RV, residual volume; FRC, functional residual capacity; TST, total sleep time; NREM, non-rapid eye movement; REM, rapid eye movement; AHI, apnea hypopnea index; SaO2, arterial O2 saturation; NS, nonsignificant.